PROTEIN RESEARCH PLAN definition

PROTEIN RESEARCH PLAN means a written plan to research and develop a THERAPEUTIC PROTEIN, as such plan is defined in the JUNE 1996 SB/HGS LICENSE AGREEMENT.
Sample 1
PROTEIN RESEARCH PLAN means a written plan to research and develop a THERAPEUTIC PROTEIN which is a COLLABORATION PRODUCT in the SB FIELD which plan includes, at a minimum, scientific data, research and development efforts, milestones, and which is sufficient to reasonably monitor diligence of the research and development of the THERAPEUTIC PROTEIN. A representative example of such a plan forms Appendix D. THERAPEUTIC PROTEIN PROPOSALS and/or RESEARCH PROGRAMS directed to the six (6) HGS PRODUCTS in Paragraph 6.3(a) are deemed to be PROTEIN RESEARCH PLANS submitted by HGS under this Agreement. 1.38."RC" shall mean the Research Committee which shall consist of three (3) appointees of HGS and three (3) appointees of SB and shall be chaired by one (1) of the SB appointees. 1.39."RESEARCH PLAN" shall mean individually and collectively a DRUG RESEARCH PLAN, ANTIBODY RESEARCH PLAN and PROTEIN RESEARCH PLAN. RESEARCH PROGRAMS (other than the one directed to [***] under the COLLABORATION AGREEMENT are deemed DRUG RESEARCH PLANS submitted by SB under this Agreement. 1.40."RESEARCH PROGRAM" shall have the meaning ascribed to it in the COLLABORATION AGREEMENT. 1.41."RESEARCH TERM EXTENSIONS" shall mean extensions of the INITIAL RESEARCH TERM obtained pursuant to Paragraph 8.6. 1.42."SB" shall mean SmithKline Xxxxxxx Corporation and/or SmithKline Xxxxxxx, p.l.c., and any past (from May 19, 1993 through the EFFECTIVE DATE), present or future AFFILIATE thereof, which AFFILIATE holds the relevant right and/or is or was or will be necessary or required to perform any obligations of SB under this Agreement and/or obligations of either of them are subsequently assigned and/or delegated pursuant to Section 25 of this Agreement. 1.43."SB/TAKEDA AGREEMENT" shall mean the agreement entered into between TAKEDA and SB effective June 8, 1995 as amended or restated and superseded as of immediately before the EFFECTIVE DATE of this Agreement which is attached as Appendix F and as may be amended from time to time. "The information below marked [***] has been omitted pursuant to a request for confidential treatment. The omitted portions have been separately filed with the Commission."
Sample 1
PROTEIN RESEARCH PLAN means a plan for research and development of a THERAPEUTIC PROTEIN which includes, at a minimum, scientific data, research and development efforts, research and development milestones, sufficient to reasonably monitor diligence of research/development of such THERAPEUTIC PROTEIN . An example of such a plan is shown in Appendix D. 8
Sample 1

Related to PROTEIN RESEARCH PLAN

  • Research Plan shall have the meaning set forth in Section 2.1.

  • Research Program has the meaning set forth in Section 2.1.

  • Research Project means a discrete scientific endeavor to answer a research question or a set of research questions related to medical marijuana and is required for a medical marijuana research license.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Research Program Term has the meaning set forth in Section 2.2.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Collaboration has the meaning set forth in Section 2.1.

  • Development Plan has the meaning set forth in Section 3.2.

  • Research Budget has the meaning set forth in Section 2.2.

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Development Program means the implementation of the development plan.

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Collaborative agreement means a voluntary, written, or electronic arrangement between one

  • Research Period means the research period as described in the Commissioned Research Plan. In accordance with the provisions of this Agreement, in the event that the Agreement ended prior to the completion date of the research originally set, the date the Agreement ends shall be read as the research period.

  • Collaborating physician means the physician who,

  • Research Term has the meaning set forth in Section 3.2.

  • Development Activities means any activity, including the discharge of dredged or fill material, which results directly in a more than de minimus change in the hydrologic regime, bottom contour, or the type, distribution or diversity of hydrophytic vegetation, or which impairs the flow, reach, or circulation of surface water within wetlands or other waters;

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Licensed Compound means [***].

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.